EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception

Inès Sellami iD, Anne Laure Barbotin iD, Valérie Bernard iD, Geoffroy Robin iD, Sophie Catteau-Jonard, Charlotte Sonigo iD, Maeliss Peigné iD

Seminars in Reproductive Medicine · 01.03.2024 · 42 (01) · 025-033

DOI: 10.1055/s-0044-1787273 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Reproductive Medicine, erschienen am 01.03.2024. Verfasst von Inès Sellami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine de la Reproduction et Préservation de la Fertilité, APHP-Université Paris-Saclay, Hôpital Antoine Béclère, Clamart, France. Hauptthemen laut MEDLINE: Anti-Mullerian Hormone, Reproductive Techniques, Assisted, Biomarkers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 116 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, the prevalence of infertility has increased, and appears to affect approximately one in six couples. Some of them must perform assisted reproductive techniques (ART) in order to achieve pregnancy. As a result, growing interest has arisen about predictive factors of pregnancy and live birth with and without ART. Anti-Mullerian hormone (AMH) is a glycoprotein discovered in the 1950s in male embryonic sexual differentiation. Later, in 1984, its role in folliculogenesis was reported: secreted by granulosa cells, this hormone is involved in the regulation of the recruitment of primordial follicles and in follicular growth. AMH assays were developed for women in 1990s, and the serum AMH level has rapidly become a crucial element in managing women's fertility. Based mainly on its ability to be a quantitative but indirect marker of ovarian reserve, the serum AMH assay is widely used in reproductive medicine and ART. This review summarizes current knowledge of the AMH assessment in the field of reproductive medicine. We focus on the role of AMH level to predict spontaneous pregnancy occurrence, ART outcomes, and fertility preservation outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Mullerian HormoneReproductive Techniques, AssistedBiomarkersHumansFemalePregnancyOvarian ReserveFertilizationMaleTreatment OutcomeFertility PreservationInfertility, FemalePregnancy Rate

Substanzen

Anti-Mullerian HormoneBiomarkers

Autor:innen und Institutionen

  • Service de Médecine de la Reproduction et Préservation de la Fertilité, APHP-Université Paris-Saclay, Hôpital Antoine Béclère, Clamart, France.
  • CHU Lille, Service de Biologie de la Reproduction, Université de Lille, Hôpital Jeanne de Flandre, Lille, France.
  • CHU Lille, Faculté de Médecine Henri Warembourg, Université de Lille, Lille Cedex, France.
  • Service de Gynécologie et Médecine de la Reproduction, Centre Aliénor d'Aquitaine, Bordeaux University Hospital, Bordeaux, France.
  • University Bordeaux, Bordeaux Institute in Oncology-BRIC-BioGo Team, INSERM U1312, Bordeaux, France.
  • CHU Lille, Service Assistance Médicale à la Procréation et Préservation de la Fertilité - Service de Gynécologie Médicale, Orthogénie et Sexologie, Hôpital Jeanne de Flandre, Lille, France.

ORCID-Profile: Inès Sellami, Anne Laure Barbotin, Valérie Bernard, Geoffroy Robin, Charlotte Sonigo, Maeliss Peigné

Zitieren

APA

Sellami, I., Barbotin, A. L., Bernard, V., Robin, G., Catteau-Jonard, S., Sonigo, C., & Peigné, M. (2024). Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception. Seminars in Reproductive Medicine, 42(01), 025-033. https://doi.org/10.1055/s-0044-1787273

Vancouver

Sellami I, Barbotin AL, Bernard V, Robin G, Catteau-Jonard S, Sonigo C, et al. Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception. Seminars in Reproductive Medicine. 2024;42(01):025-033. doi:10.1055/s-0044-1787273

BibTeX
@article{Sellami2024,
  author = {Sellami, Inès and Barbotin, Anne Laure and Bernard, Valérie and Robin, Geoffroy and Catteau-Jonard, Sophie and Sonigo, Charlotte and Peigné, Maeliss},
  title = {Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception},
  journal = {Seminars in Reproductive Medicine},
  year = {2024},
  volume = {42},
  number = {01},
  pages = {025--033},
  doi = {10.1055/s-0044-1787273}
}
Kostenlos starten →